Related Experiment Videos
MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda
George Wells1, Jennifer Anderson, Maarten Boers
1Department of Clinical Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.
The Journal of Rheumatology
|May 8, 2003
Abstract:
The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.